News & Updates
Filter by Specialty:

Expectant mums’ use of dolutegravir safe for babies
07 Aug 2024
byJairia Dela Cruz
Treatment with dolutegravir during pregnancy does not appear to pose an excess risk of adverse birth outcomes, according to two studies presented at the 24th International AIDS Conference in Montreal, Canada.
Expectant mums’ use of dolutegravir safe for babies
07 Aug 2024
High oxytocin dose helps reduce postpartum haemorrhage
06 Aug 2024
byStephen Padilla
Use of high-dose oxytocin postpartum appears to result in reduced rates of postpartum haemorrhage (PPH) when compared with traditional doses, as shown in a study presented at SMFM 2024.